M. Bröring et al. / Inorganica Chimica Acta 374 (2011) 572–577
573
170 °C (C50H29BF24N6OPdS2 Â CH2Cl2 requires: C, 42.18; H, 2.15;
N, 5.79. Found: C, 42.13; H, 2.57; N, 6.02%). 1H NMR (CD2Cl2,
295 K): d 2.02 (br s, 3H, acetamide), 2.57 (s, 6H, 4-MeTh), 6.40–
6.71 (br s, 2H, NH2), 6.98 (s, 2H, 5-CHTh), 7.56 (s, 4H, p-CH F),
7.71–7.74 (m, 10H, b-CH + o-CHBArF), 8.02–8.04 ppm (m, 2HB,Ara
-
CH). 13C NMR (CD2Cl2, 295 K): d 19.3, 115.9, 117.9 (m, p-CHBArF),
1
123.4, 125.0 (q, JC–F = 271 Hz, CF3), 129.1 (m, m-CBArF), 133.1,
135.2, 136.6, 150.2, 154.1, 162.0 (m, BCBArF), 167.6 ppm; the
remaining signal for the acetamide could not be detected. 19F
NMR (CD2Cl2, 295 K): d À65.5 ppm.
Fig. 1. Conformational dynamics observed for palladium complexes with sterically
hindered tripyrrin ligands.
2.3.3. [(4-Mebti)Pd(dmf)]+ BArFÀ (3) and [(4-Mebti)Pd(OCHO)] (4)
A mixture of toluene and DMF (60:1) was used for the prepara-
tion. Single crystals of 3 were obtained by diffusion of n-pentane
into a dichloromethane solution at À20 °C. (15.7 mg, 54%), mp
132 °C (decomp.) (C51H31BF24N6OPdS2 requires: C, 44.36; H, 2.26;
N, 6.08. Found: C, 43.92; H, 2.41; N, 5.99%). 1H NMR (CD2Cl2,
295 K): d 2.60 (s, 6H, 4-MeTh), 2.98 (s, 3H, dmf), 3.01 (s, 3H, dmf),
6.91 (s, 2H, 5-CHTh), 7.56 (s, 4H, p-CHBArF), 7.66–7.69 (m, 2H, b-
numbering scheme for the assignment of the resonance signals is
given in Chart 1. In the case of 19F NMR spectra, CFCl3 was used
as external reference. Elemental analyses were carried out on an
Elementar Vario EL instrument. Melting points were determined
on a Büchi SMP-20 in open capillaries and are not corrected.
2.2. Single crystal X-ray structural determinations
CH), 7.73 (br s, 8H, o-CHBArF), 7.89–7.92 ppm (m, 2H,
a-CH), 8.01
Experimental details relating to the crystallographic character-
ization are summarized in Table 1. Diffraction data were collected
(s, 1H, dmf). 13C NMR (CD2Cl2, 295 K): d 19.7, 33.5, 38.2, 115.2,
1
117.4 (m, p-CHBArF), 123.0, 124.7 (q, JCÀF = 273 Hz, CF3), 128.9
using graphite monochromated Mo K
instrument at 193(2) K using -scans, or on a Stoe IPDS-II at
173(2) K using -scans. The structures were solved by direct meth-
a radiation on a Stoe IPDS-I
(m, m-CBArF), 132.6, 134.7, 136.3, 149.5, 153.7, 161.9 (m, BCBArF),
166.3, 166.8 ppm. 19F NMR (CD2Cl2, 295 K): d À62.9 ppm. If wet
THF is added to the crystallization mixture, a small deposit of crys-
tals of the formiate complex 4 forms over several days.
U
x
ods and refined against F2 by least-squares utilizing the software
packages SHELXL-97 [14], SIR-92 [15], PLATON [16], and WINGX [17]. All
non-hydrogen atoms were refined anisotropically. Hydrogen
atoms were placed in calculated positions and refined using a rid-
ing model. Selected bond lengths, distances and angles for 2–7 are
given in Table 2.
2.3.4. [(4-Mebti)Pd(OC(NHPh)2)]+ BArFÀ (5)
Wet toluene and phenylisocyanate (0.1 mL, 92 lmol) were used
for the preparation. Single crystals of 5 were obtained by diffusion
of n-pentane into a dichloromethane solution at À20 °C. (10.2 mg,
58%), mp 172 °C (decomp.) (C61H36BF24N7OPdS2 requires: C, 48.19;
H, 2.39; N, 6.45. Found: C, 47.47; H, 2.95; N, 7.27%). 1H NMR
(CD2Cl2, 295 K): d 2.61 (s, 6H, 4-MeTh), 6.84 (s, 2H, 5-CHTh), 7.10–
7.28 (m, 10H, CHPh), 7.56 (s, 4H, p-CHBArF), 7.64 (s, 2H, b-CH),
2.3. Syntheses of complexes
2.3.1. General procedure
[(4-Mebti)PdCl] 1 (10.0 mg, 21
l
mol) was dissolved in dry tolu-
a
-CH + o-CHBArF); the NH signal was not detected.
ene or dichloromethane (2 mL), and NaBArF (18.7 mg, 21
l
mol)
7.73 (m, 10H,
13C NMR (CD2Cl2, 295 K): d 19.8, 115.0, 117.5 (m, p-CHBArF),
was added in one portion. The mixture was stirred for 5 min before
the neutral ligand was added, and stirring continued for 16 h. If a
red solid has precipitated, the solvent was removed in vacuum
and the solid extracted with dry dichloromethane. After filtration
on celite the solvent was removed again, the residue washed with
pentane, and dried in vacuum. If the product remained in solution,
the reaction mixture was directly filtered and treated as described.
Purification was achieved by crystallization as detailed below for
each case.
1
122.9, 123.0, 124.7 (q, JC–F = 270 Hz, CF3), 126.5, 129.0 (m,
m-CBArF), 129.8, 132.6, 134.9, 135.9, 136.2, 149.8, 153.4, 162.0 (m,
BCBArF), 166.2; the carbonyl carbon atom was not detected. 19F
NMR (CD2Cl2, 295 K): d À65.4 ppm.
2.3.5. [(4-Mebti)Pd(SMe2)]+ BArFÀ (6)
A mixture of toluene and dimethylsulfide (25:1) was used for
the preparation. Single crystals of 6 were obtained by diffusion of
n-pentane into a dichloromethane solution at À20 °C. (18.7 mg,
65%), mp 163–166 °C (C50H30BF24N5PdS3 Â 1.86 CH2Cl2 (from the
crystallographic analysis) requires: C, 40.59; H, 2.23; N, 4.57.
Found: C, 40.62; H, 2.42; N, 4.44%). 1H NMR (CD2Cl2, 295 K): d
2.14 (s, 6H, Me2S), 2.77 (s, 6H, 4-MeTh), 7.13 (s, 2H, 5-CHTh), 7.56
(br s, 4H, p-CHBArF), 7.73 (br s, 8H, o-CHBArF), 7.76 (m, 2H, b-CH),
2.3.2. [(4-Mebti)Pd(OC(NH2)Me)]+ BArFÀ (2)
Purified acetamide (5.9 mg, 100 lmol) and dichloromethane
were used for the preparation. Single crystals of 2 were obtained
after double recrystallization from toluene/n-pentane and dichlo-
romethane/n-pentane, respectively. (14.6 mg, 51%), mp 168–
Chart 1. Nomenclature and numbering systems for the spectroscopic assignments.